Jeevan Scienti.

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE237B01018
  • NSEID:
  • BSEID: 538837
INR
68.61
-1.4 (-2.0%)
BSENSE

Feb 12

BSE+NSE Vol: 5.63 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
19.07
12.38
8.80
10.06
12.51
11.40
12.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
19.07
12.38
8.80
10.06
12.51
11.40
12.88
Raw Material Cost
1.49
1.00
0.77
1.15
0.85
0.80
0.99
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
5.55
5.10
5.02
4.99
4.03
4.05
3.99
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
6.80
4.21
4.79
4.30
5.55
4.05
4.68
Total Expenditure (Excl Depreciation)
13.84
10.31
10.58
10.44
10.43
8.90
9.66
Operating Profit (PBDIT) excl Other Income
5.23
2.07
-1.78
-0.38
2.08
2.50
3.22
Other Income
0.14
0.20
0.33
0.15
0.23
0.16
0.11
Operating Profit (PBDIT)
5.37
2.27
-1.45
-0.23
2.31
2.66
3.33
Interest
0.54
0.55
0.54
0.55
0.43
0.45
0.33
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
4.83
1.72
-1.99
-0.78
1.88
2.21
3.00
Depreciation
1.60
1.69
1.74
1.77
1.48
1.49
1.51
Profit Before Tax
3.23
0.03
-3.73
-2.55
0.39
0.72
1.49
Tax
0.83
0.02
-0.51
-1.29
0.35
0.47
0.47
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2.40
0.01
-3.22
-1.26
0.05
0.25
1.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2.40
0.01
-3.22
-1.26
0.05
0.25
1.03
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.98
0.10
-0.12
0.04
-0.06
0.01
-0.06
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1.42
-0.09
-3.10
-1.30
0.11
0.24
1.09
Equity Capital
15.83
15.83
15.83
15.83
15.83
15.48
15.48
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
0.9
-0.06
-1.96
-0.82
0.07
0.16
0.7
Diluted Earnings per share
1.52
0.01
-2.03
-0.79
0.03
0.16
0.66
Operating Profit Margin (Excl OI)
27.43%
16.72%
-20.23%
-3.78%
16.63%
21.93%
25.0%
Gross Profit Margin
25.33%
13.89%
-22.61%
-7.75%
15.03%
19.39%
23.29%
PAT Margin
12.59%
0.08%
-36.59%
-12.52%
0.4%
2.19%
8.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 52.44% vs 23.49% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 1,190.91% vs 122.92% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 151.44% vs 103.92% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is 25.58% vs 186.67% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Jeevan Scienti. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
19.07
0
19.07
Other Operating Income
0.00
0.00
0.00
Total Operating income
19.07
0
19.07
Raw Material Cost
1.49
0
1.49
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.00
0
0.00
Employee Cost
5.55
0
5.55
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
6.80
0.00
6.80
Total Expenditure (Excl Depreciation)
13.84
0
13.84
Operating Profit (PBDIT) excl Other Income
5.23
0.00
5.23
Other Income
0.14
0
0.14
Operating Profit (PBDIT)
5.37
0
5.37
Interest
0.54
0
0.54
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
4.83
0
4.83
Depreciation
1.60
0
1.60
Profit Before Tax
3.23
0
3.23
Tax
0.83
0
0.83
Provisions and contingencies
0.00
0
0.00
Profit After Tax
2.40
0
2.40
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
2.40
0
2.40
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.98
0
0.98
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1.42
0
1.42
Equity Capital
15.83
0
15.83
Face Value
10.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
0.90
0
0.90
Diluted Earnings per share
1.52
0
1.52
Operating Profit Margin (Excl OI)
27.43%
0%
0.00
27.43%
Gross Profit Margin
25.33%
0%
0.00
25.33%
PAT Margin
12.59%
0%
0.00
12.59%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 19.07 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 54.04% vs 40.68% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 52.44% vs 23.49% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.42 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 1,677.78% vs 97.10% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 1,190.91% vs 122.92% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.23 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is 152.66% vs 216.29% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 151.44% vs 103.92% in Dec 2024

Quarterly - Interest
Interest 0.54 Cr
in Dec 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Dec 2025 is -1.82% vs 1.85% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 25.58% vs 186.67% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.43%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024